Eventide Asset Management, LLC Wave Life Sciences Ltd. Transaction History

Eventide Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$22.93 - $42.84 $3.91 Million - $7.3 Million	-170,400 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$36.35 - $55.2 $5.67 Million - $8.61 Million	-156,000 Reduced 47.79%	170,400 $8.52 Million
Q2 2018 Aug 14, 2018	SELL	$33.85 - $50.65 $1.75 Million - $2.61 Million	-51,600 Reduced 13.65%	326,400 $12.5 Million
Q1 2018 May 15, 2018	SELL	$32.45 - $54.7 $1.8 Million - $3.04 Million	-55,500 Reduced 12.8%	378,000 $15.2 Million
Q3 2017 Nov 14, 2017	BUY	$16.4 - $25.05 $7.11 Million - $10.9 Million	433,500	433,500 $9.43 Million

164

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.24B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.